8-81531265-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001105281.6(FABP12):c.51C>T(p.Ser17Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00299 in 1,606,768 control chromosomes in the GnomAD database, including 21 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0052 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0028 ( 19 hom. )
Consequence
FABP12
NM_001105281.6 synonymous
NM_001105281.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.426
Genes affected
FABP12 (HGNC:34524): (fatty acid binding protein 12) Predicted to enable lipid binding activity. Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 8-81531265-G-A is Benign according to our data. Variant chr8-81531265-G-A is described in ClinVar as [Benign]. Clinvar id is 789297.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.426 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FABP12 | NM_001105281.6 | c.51C>T | p.Ser17Ser | synonymous_variant | 2/5 | NP_001098751.1 | ||
FABP12 | XM_006716465.4 | c.51C>T | p.Ser17Ser | synonymous_variant | 2/5 | XP_006716528.1 | ||
FABP12 | XM_011517577.3 | c.51C>T | p.Ser17Ser | synonymous_variant | 3/6 | XP_011515879.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FABP12 | ENST00000360464.6 | c.51C>T | p.Ser17Ser | synonymous_variant | 2/5 | 1 | ENSP00000353650.4 | |||
FABP12 | ENST00000692030.1 | c.51C>T | p.Ser17Ser | synonymous_variant | 3/6 | ENSP00000510293.1 | ||||
FABP12 | ENST00000519696.1 | n.3C>T | non_coding_transcript_exon_variant | 1/4 | 5 | ENSP00000427973.1 | ||||
ENSG00000253374 | ENST00000523380.5 | n.506-1657G>A | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00513 AC: 780AN: 152062Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
780
AN:
152062
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00356 AC: 849AN: 238500Hom.: 3 AF XY: 0.00379 AC XY: 488AN XY: 128786
GnomAD3 exomes
AF:
AC:
849
AN:
238500
Hom.:
AF XY:
AC XY:
488
AN XY:
128786
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00277 AC: 4024AN: 1454588Hom.: 19 Cov.: 29 AF XY: 0.00301 AC XY: 2172AN XY: 722630
GnomAD4 exome
AF:
AC:
4024
AN:
1454588
Hom.:
Cov.:
29
AF XY:
AC XY:
2172
AN XY:
722630
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00515 AC: 784AN: 152180Hom.: 2 Cov.: 32 AF XY: 0.00511 AC XY: 380AN XY: 74376
GnomAD4 genome
AF:
AC:
784
AN:
152180
Hom.:
Cov.:
32
AF XY:
AC XY:
380
AN XY:
74376
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
19
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 17, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at